Skip to main content
. 2008 Dec 29;53(4):1450–1456. doi: 10.1128/AAC.01027-08

TABLE 4.

Individual pharmacokinetics of caspofungin in infants/toddlers

Patient Age (mo) AUC0-24 (μg/ml·h)
C1 (μg/ml)
C24 (μg/ml)
β-Phase t1/2 (h)
CL (ml/min/m2)
Day 1 Day 4 Day 1 Day 4 Day 1 Day 3-14a Day 1 Day 4 Day 1
1 12 109.4 135.0 17.53 24.79 0.65 0.94 5.02 10.51 7.30
2 10 159.6 114.0 14.47 15.17 2.38 1.55 9.00 9.15 4.37
3 12 119.5 122.0 18.26 15.94 1.03 1.26 6.64 6.17 6.44
4 13 121.4 15.75 16.87 1.48 8.35
5 17 146.3 135.3 23.91 16.42 1.85 1.60 8.37 7.33 4.94
6 20 97.4 122.0 13.00 12.14 1.55 2.16 11.07 11.41 6.82
7 17 101.7 13.90 1.15 8.59 7.19
8 12 128.9 22.30 17.96 1.72 8.58
9 22 119.9 171.1 21.50 21.30 1.51 3.17 8.97 12.13 5.98
Mean 121.97 131.21 17.85 17.57 1.45 1.74 7.79b 8.8b 6.15
SD 23.06 17.69 3.95 3.89 0.57 0.68 2.31b 2.1b 1.12
Geometric mean 120.2 130.28 17.46 17.21 1.34 1.64 6.05c
a

Time-averaged parameters determined as the geometric mean of all values obtained between days 3 and 14.

b

Harmonic means (jackknife standard deviations) are reported for β-phase t1/2.

c

95% CI for the geometric mean, (4.92, 7.45).